Telehealth Insomnia Prescribing: What Prescribers Can Do in California

If you’re a psychiatrist or PMHNP considering treating insomnia patients via telehealth, you’re probably asking: Can I legally prescribe Ambien or other sleep medications remotely? What about controlled substances? Do I need an in-person visit first?

The short answer: Yes, psychiatrists can prescribe insomnia medications via telehealth in 2026 — including controlled substances like zolpidem (Ambien), eszopiclone (Lunesta), and temazepam. Thanks to extended DEA flexibilities through December 31, 2025, you can initiate controlled sleep medications without a prior in-person exam, provided you’re licensed in the patient’s state and conduct a proper video evaluation.

For PMHNPs, the answer is more nuanced — your prescribing authority depends heavily on which state you’re practicing in.

This guide walks through everything you need to know: scope of practice differences between psychiatrists and PMHNPs, state-by-state prescribing rules, telehealth regulations for controlled substances, and the practical economics of building an insomnia-focused telehealth practice.

Psychiatrist vs PMHNP Authority for Insomnia Prescribing

What Psychiatrists Can Do

As a board-certified psychiatrist (MD/DO), you have full prescribing authority in all 50 states for insomnia treatment. There are no supervision requirements, no specialty-specific restrictions, and no state-by-state variations in your scope.

You can:

• Conduct comprehensive insomnia evaluations via video
• Prescribe any FDA-approved sleep medication (controlled or non-controlled)
• Initiate Schedule IV hypnotics (zolpidem, eszopiclone, temazepam) on a first telehealth visit
• Treat underlying psychiatric conditions contributing to insomnia (anxiety, depression)
• Order sleep studies or labs if clinically indicated
• Provide ongoing medication management entirely via telehealth

The only constraint: you must hold an active medical license in the state where your patient is physically located during the visit. If you see patients in multiple states, you need licensure in each — though the Interstate Medical Licensure Compact (IMLC) streamlines this process. Texas and Illinois are IMLC states among our focus markets.

What PMHNPs Can Do (It Depends on Your State)

PMHNPs are increasingly filling the psychiatry shortage gap, but your prescribing authority for insomnia varies dramatically by state. Here’s the breakdown:

Full Practice States (Independent Authority)In states with full practice authority, experienced PMHNPs can practice exactly like psychiatrists for insomnia treatment — no physician oversight required.

• California: After completing a 3-year supervised transition as a ‘103 NP’ (working in a group with a physician on site), PMHNPs become ‘104 NPs’ with full independent practice within their psychiatric specialty. Many experienced psych NPs are reaching this status in 2026.

• New York: PMHNPs with ≥3,600 clinical hours (roughly 2 years full-time) can practice completely independently — no collaborative agreement needed. You can evaluate patients, diagnose insomnia, and prescribe all sleep medications (including controlled substances) on your own authority.

• Illinois: After 4,000 hours of supervised practice plus 250 continuing education hours in psychiatry, you can apply for Full Practice Authority status. Once approved, you can prescribe independently, though Illinois law requires physician consultation after 30 days for Schedule II substances (which rarely applies to insomnia — most sleep meds are Schedule IV).

Reduced Practice States (Collaboration Required)These states require a formal physician collaboration agreement, but it’s typically a paper relationship rather than day-to-day supervision.

• New York (for newer NPs): Before hitting 3,600 hours, you need a written collaborative agreement with a psychiatrist or physician. They don’t need to see your patients, but the agreement must outline your scope and provide for consultation on complex cases.

• Illinois (before FPA): Initially, you practice under a physician’s delegated prescriptive authority. Your collaborating physician must be available for consults, but you manage the day-to-day treatment independently.

Restricted Practice States (Active Supervision Required)These states impose significant barriers that affect your ability to deliver telehealth insomnia care independently.

• Texas: You must have a Prescriptive Authority Agreement with a Texas physician, including monthly quality assurance meetings and regular chart reviews. Your supervising physician can oversee up to 7 advanced practice providers. You cannot prescribe Schedule II controlled substances in outpatient settings (though most insomnia meds are Schedule IV, so this rarely impacts sleep treatment). For telehealth platforms, this means you’ll need the company to provide or arrange a supervising physician.

• Florida: Psychiatric NPs are explicitly excluded from Florida’s autonomous practice law. You must practice under a physician protocol and supervision agreement. Florida also limits NPs to 7-day supplies of Schedule II medications (though again, typical insomnia drugs like Ambien are Schedule IV). Only psychiatric-certified APRNs can prescribe controlled psychiatric medications to minors in Florida.

• Pennsylvania: Perhaps the most restrictive state — you need collaborative agreements with two physicians, and you cannot prescribe more than a 30-day supply of Schedule II or 90 days of Schedule III-IV without physician re-evaluation. For chronic insomnia patients on long-term Ambien, this means quarterly physician consults are legally required.

The Bottom Line: If you’re a PMHNP in California, New York (with experience), or Illinois (with FPA), you can build a thriving telehealth insomnia practice with full autonomy. In Texas, Florida, or Pennsylvania, you’ll need physician collaboration — which isn’t insurmountable, but adds administrative overhead and may limit your flexibility.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Telehealth Rules for Prescribing Controlled Sleep Medications

Here’s where many providers get confused: the DEA’s Ryan Haight Act historically required an in-person exam before prescribing any controlled substance via telemedicine. During COVID-19, this requirement was waived — and those flexibilities have been repeatedly extended.

Current Status (2026)

As of February 2026, you can prescribe controlled substances (including Schedule IV sleep medications) via telehealth without a prior in-person visit, under temporary DEA rules extended through December 31, 2025.

This means:

• A new patient can schedule a video visit with you
• You conduct a thorough evaluation (clinical interview, sleep history, mental status exam)
• If appropriate, you prescribe zolpidem, eszopiclone, temazepam, or other controlled sleep medications
• The prescription is sent electronically to their pharmacy
• No in-person exam is required initially or for follow-up

These flexibilities were extended to give the DEA time to finalize permanent telemedicine prescribing rules. The expectation is that by late 2026, new regulations will be in place — likely requiring either periodic in-person visits for long-term controlled substance patients or a special DEA telemedicine registration. Stay alert for these updates, as requirements could change.

What This Means for Your Practice

For now, telehealth insomnia prescribing is wide open. You can see patients anywhere in states where you’re licensed, initiate treatment remotely, and manage ongoing care entirely via video. Most telehealth platforms are structured to capitalize on this flexibility while it lasts.

If DEA rules change to require in-person visits (say, once annually for patients on chronic hypnotics), platforms will need to help coordinate local exams — but that’s a future concern, not a current barrier.

State-Specific Prescribing Requirements

Beyond DEA rules, individual states layer on additional requirements. Here’s what matters for insomnia prescribing:

Prescription Drug Monitoring Programs (PDMPs)

Nearly every state requires you to check the state PDMP before prescribing controlled substances — and often periodically thereafter. This is critical for insomnia treatment, since you’re prescribing drugs with abuse potential.

Texas: You must check the PDMP before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol. While zolpidem isn’t explicitly listed, best practice is to check for all controlled substances.

New York: The I-STOP PDMP check is mandatory for every Schedule II-IV prescription. You need to document that you checked within 24 hours before prescribing. Non-compliance risks board action.

California: Requires CURES (CA’s PDMP) registration. You must check at least every 4 months for patients on ongoing controlled substance therapy.

Illinois: Mandates PDMP checks for opioids and benzodiazepines. While not technically required for non-benzo hypnotics, checking for all controlled substances is standard practice.

For multi-state telehealth practice, this means maintaining PDMP access in each state — which can be administratively burdensome but is non-negotiable.

Informed Consent for Telehealth

Most states require patient consent for telemedicine treatment, though the specifics vary. Generally, you need to:

• Explain what telehealth is and how it differs from in-person care
• Discuss potential risks (technology failures, privacy concerns)
• Confirm the patient understands and consents

This is typically documented in your EMR. Some platforms handle this automatically with a consent form at registration.

Audio-Only Prescribing Restrictions

Many states restrict or prohibit prescribing controlled substances based solely on phone (audio-only) consultations. Video visits are almost universally required for initiating controlled medications.

Exception: Some states (like Illinois for Medicaid patients) allow audio-only for established behavioral health patients in specific circumstances — but for new insomnia patients, plan on video being required.

Comparing Insomnia Treatment to Other Psychiatric Specialties

If you’re coming from general psychiatry or considering focusing on insomnia, here’s how the prescribing landscape differs:

Depression/Anxiety: First-line medications (SSRIs, SNRIs) are non-controlled, long-term, and considered standard of care. Prescribing is straightforward, refills are routine, and there’s minimal regulatory scrutiny.

ADHD: Stimulant prescribing (Schedule II) faces the most restrictions. Many states limit NP prescribing authority, require frequent follow-ups, and impose strict quantity limits. Telehealth stimulant prescribing has been controversial politically.

Insomnia: Sits in the middle — medications are mostly Schedule IV (less restricted than stimulants, more than antidepressants), but chronic use raises concerns about tolerance and dependence. Clinical guidelines emphasize short-term pharmacotherapy combined with behavioral interventions (CBT-I).

This creates a unique prescribing philosophy for insomnia:

• Start with lowest effective dose
• Plan for time-limited use (weeks to months, not indefinite)
• Reassess regularly (often every 2-4 weeks initially)
• Consider taper strategies and alternative approaches
• Document rationale for long-term use carefully

You’re not just prescribing — you’re actively managing a treatment course with an exit strategy, which differs from maintenance treatment for chronic conditions.

The Economics of Telehealth Insomnia Treatment

Let’s talk business. Can you build a financially sustainable practice treating insomnia via telehealth?

Reimbursement Rates

Medication management visits for insomnia typically run 15-30 minutes and are billed using E/M codes:

• CPT 99213 (20-minute established patient visit): ~$95 (Medicare national average)
• CPT 99214 (30-minute visit): ~$125

Private insurance often pays 10-20% above Medicare rates, so expect $90-150 per visit depending on complexity and payor.

Telehealth Parity: As of 2026, 24 states plus DC have laws requiring private insurers to reimburse telehealth at the same rate as in-person visits. This includes California, New York, Illinois, and Texas among our focus states. There’s no financial penalty for delivering care remotely.

Medicare also covers tele-psychiatry at parity — and has repeatedly extended pandemic-era flexibilities allowing mental health visits to be conducted entirely via telehealth (though watch for potential future requirements around periodic in-person visits).

Patient Volume Considerations

Insomnia med-checks are efficient:

• Initial evaluation: 30-45 minutes
• Follow-ups: 15-20 minutes
• Most patients need monthly or less frequent visits once stable

Compare this to weekly therapy sessions — you can see more patients per hour with medication management, which increases revenue potential.

However, don’t expect every patient to become a long-term recurring visit. Good insomnia treatment often means tapering patients off medications as their sleep improves — which is clinically appropriate but means you need consistent new patient flow.

The Real Cost of DIY Patient Acquisition

Here’s where many providers miscalculate when comparing platforms to solo practice: acquiring psychiatric patients yourself is expensive and time-consuming.

Let’s be realistic about what self-marketing actually costs:

SEO (Search Engine Optimization)

• Takes 6-12 months of consistent investment before generating meaningful patient flow
• Requires technical expertise most clinicians don’t have
• Typical cost: $1,500-3,000/month for quality SEO services
• You’re competing against established practices, directories, and platforms that have been investing for years

Google Ads

• Mental health keywords cost $15-40+ per click
• Most clicks don’t convert to booked appointments
• You’ll test multiple ads, landing pages, and keywords before finding what works
• Realistic cost per booked patient: $200-400+ (when you factor in wasted clicks and no-shows from cold leads)

Directory Listings

• Psychology Today: ~$30/month but you’re one of hundreds of providers on the page
• Zocdoc: ~$300/month subscription plus $35-100 per booking
• Total monthly cost across multiple directories: $500-1,000+
• Conversion rates vary wildly by market saturation

Agency/Consultant Fees

• If you hire help (which most providers eventually do): $2,000-5,000/month
• You’re still paying this whether you get 5 patients or 50

Staff Time

• Someone needs to handle phone calls, qualify leads, schedule appointments
• Cold leads from ads require screening to avoid no-shows
• Factor in your opportunity cost or staff salary

The Reality: Most solo practitioners spend $3,000-5,000/month on marketing with highly variable results. In months when it works, your cost per patient might be $150-200. In months when it doesn’t (new ad algorithm, seasonal slowdown, competitor enters market), you’ve burned thousands with nothing to show.

Contrast this with a pay-per-appointment model like Klarity Health: you pay a standard fee only when a qualified patient books with you. No upfront spend, no wasted ad budget, no gambling on marketing channels that might not work.

The math is straightforward: Would you rather spend $4,000/month hoping to acquire 15-20 patients through your own marketing, or pay only when patients actually show up?

Platform Economics vs. Solo Practice

Let’s compare your real options:

DIY Marketing Approach

• Monthly marketing spend: $3,000-5,000
• Patient acquisition: 10-20 patients/month (if your marketing works)
• Cost per patient: $150-250+
• Risks: No guarantees, highly variable results, requires months of investment before seeing returns
• Hidden costs: Your time managing marketing, staff time qualifying leads, no-show rates

Klarity Health Platform Model

• Monthly marketing spend: $0
• Patient acquisition: Variable based on your availability and specialty
• Cost per patient: Standard listing fee per new appointment
• Risks: None — you only pay when a patient books
• Benefits: Pre-qualified patients, built-in telehealth platform, both insurance and cash-pay, you control your schedule

The value proposition: Platforms remove the marketing risk entirely. Instead of spending thousands gambling on SEO or Google Ads that might not work, you pay a predictable fee only for actual booked appointments. For providers starting out, scaling up, or those who simply don’t want to become marketing experts, this model guarantees ROI.

What About Cash-Pay?

Some providers wonder about building a direct-pay insomnia practice. The challenge: most patients expect insurance coverage for mental health, and insomnia medication management doesn’t command the premium rates that specialized services (like TMS or ketamine) do.

Cash-pay rates for psychiatry typically run $200-300 for initial evaluations, $100-150 for follow-ups. That’s competitive with insurance reimbursement, but without insurance your patient pool is limited to those willing and able to pay out-of-pocket.

For most providers, the smart play is accepting insurance (or joining a platform that handles insurance credentialing), which maximizes your addressable market.

Building Your Telehealth Insomnia Practice: Practical Workflow

What does treating insomnia via telehealth actually look like day-to-day?

Initial Evaluation (30-45 minutes)

Clinical Assessment:

• Detailed sleep history (sleep onset, maintenance, early morning awakening)
• Sleep diary review (ideally patient completes 1-2 weeks before visit)
• Mental health screening (insomnia is often comorbid with depression, anxiety, PTSD)
• Medical history (pain conditions, sleep apnea risk, medication list)
• Substance use (alcohol, caffeine, cannabis)
• Sleep hygiene and environment review

Diagnostic Considerations:You need to rule out conditions that require different treatment:

• Sleep apnea: Snoring, witnessed apneas, daytime sleepiness, large neck circumference → refer for sleep study
• Restless legs syndrome: Uncomfortable leg sensations relieved by movement → consider iron studies, dopaminergic agents
• Circadian rhythm disorders: Shift work, delayed sleep phase → light therapy, melatonin timing
• Medication-induced insomnia: Stimulants, steroids, some antidepressants

Treatment Planning:First-line treatment for chronic insomnia is CBT-I (Cognitive Behavioral Therapy for Insomnia) — not medication. However, many patients need pharmacotherapy for short-term relief or as a bridge while engaging in behavioral treatment.

Your plan might include:

• Sleep hygiene education (often provided as handouts or video modules)
• Recommendation for CBT-I (digital programs like Sleepio, or referral to a psychologist)
• Medication if appropriate: start with lowest effective dose
• Follow-up in 2 weeks to assess response

Prescribing Decision:For pharmacotherapy, you’re choosing between:

• Non-controlled options: Trazodone (off-label), doxepin (low-dose), melatonin, ramelteon
• Schedule IV hypnotics: Zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), temazepam
• Dual orexin receptor antagonists: Suvorexant (Belsomra), lemborexant (Dayvigo) — newer, less dependence risk but expensive

You check the state PDMP if prescribing a controlled substance, document your rationale, send the e-prescription, and schedule follow-up.

Follow-Up Visits (15-20 minutes)

These typically occur every 2-4 weeks initially, then monthly or quarterly once stable.

What You’re Assessing:

• Efficacy: How has sleep improved? (Use standardized measures like Insomnia Severity Index)
• Side effects: Next-day sedation? Sleep-walking? Cognitive impairment?
• Tolerance: Is the patient requesting dose increases?
• Behavioral progress: Are they engaging with CBT-I? Improving sleep hygiene?
• Readiness to taper: Can we reduce dose or frequency?

Prescribing Follow-Up:

• Refill medications if working well
• Adjust dose if inadequate response (within standard dosing ranges)
• Switch agents if side effects or inadequate response
• Taper plan if sleep has normalized (e.g., reducing from nightly to as-needed use)

Documentation:Your notes should clearly document:

• Current symptoms and functional impact
• PDMP checked (if applicable)
• Risk-benefit discussion if continuing controlled substances
• Plan for duration of treatment

This documentation matters for billing, malpractice protection, and state board compliance.

Long-Term Management Strategy

Unlike treating hypertension (where medication is indefinite), insomnia treatment should have an endpoint. Best practice:

• Time-limited trials: Start with ‘Let’s try this for 4-6 weeks and reassess’
• Intermittent dosing: For chronic insomnia, consider 3-4 nights per week rather than nightly
• Periodic taper attempts: Every 3-6 months, discuss tapering
• Behavioral emphasis: Patients doing CBT-I are much more likely to successfully discontinue meds

For the subset of patients with chronic, severe insomnia who truly benefit from long-term pharmacotherapy, document clearly why continued treatment is appropriate (e.g., multiple failed taper attempts, severe functional impairment when off medication, patient preference after informed consent discussion).

State Licensing and Multi-State Practice

The biggest operational hurdle for telehealth: you must be licensed in every state where your patients are located.

Licensure Options

For Psychiatrists (MDs/DOs):

• Interstate Medical Licensure Compact (IMLC): Streamlines getting licenses in multiple states. Among our focus states, Texas and Illinois are members. You apply through your home state board, and expedited licenses are issued in other compact states. Costs vary but expect $700-1,500 per state.

• Individual state licensure: For non-compact states (CA, NY, FL, PA), you apply directly to each state medical board. Processing times: 60-120 days typically. Total cost per license: $500-1,000+.

For PMHNPs:

• APRN Compact: Several states have enacted this (including Illinois), but it’s not yet operational as of 2026. When active, it will work like the IMLC for nurse practitioners.

• Individual state APRN licensure: Currently, you must apply to each state board of nursing separately. Requirements include submitting national certification, graduate transcripts, background checks. Cost: $100-500 per state.

Florida’s Telehealth Registration: Florida offers a shortcut — out-of-state providers can register as telehealth providers without full Florida licensure, provided they’re licensed elsewhere and meet certain criteria (no disciplinary action, etc.). Registration fee is nominal (~$100-200). This is unique to Florida and can make entering that market easier.

Platform Support

If you join a telehealth platform like Klarity Health, they typically:

• Advise which states to prioritize (based on patient demand and your credentials)
• Provide reimbursement for licensure fees in some cases
• Handle credentialing with insurance networks in those states
• Match you with patients only in states where you’re licensed

Solo practice means handling all this yourself — which is feasible but time-consuming.

Frequently Asked Questions

Can I prescribe Ambien to a new patient on the first telehealth visit?

Yes, under current federal rules (extended through December 31, 2025). You must conduct a thorough video evaluation, document your clinical reasoning, check the state PDMP, and ensure the patient is located in a state where you’re licensed. You cannot prescribe based on a phone call alone — video is required for controlled substances.

Do PMHNPs need physician supervision to prescribe sleep medications?

It depends on your state. In full practice authority states (27 states + DC), experienced PMHNPs can prescribe independently. In restricted states like Texas, Florida, and Pennsylvania, you need a formal physician collaboration agreement. Check your state’s board of nursing rules or consult the table earlier in this article.

What if the DEA changes the rules after 2025?

The DEA is expected to finalize permanent telemedicine prescribing regulations by late 2026. Potential changes might include requiring at least one in-person visit annually for chronic controlled substance patients, or creating a special telemedicine DEA registration. Monitor DEA announcements and consider joining platforms that will handle compliance changes for you.

How do I check the prescription drug monitoring program in multiple states?

Each state has its own PDMP system with separate registration. You’ll need to:

• Register as a provider in each state’s PDMP (usually through the state board or health department)
• Maintain login credentials for each system
• Check before prescribing controlled substances (frequency varies by state — some require checks at every prescription, others quarterly)

Many EMR systems are integrating PDMP access to streamline this, but it remains one of the administrative burdens of multi-state practice.

Is treating insomnia as profitable as treating ADHD or depression?

Revenue per patient is similar — med management visits bill at the same rates regardless of diagnosis. However, insomnia treatment often involves shorter treatment courses (patients ideally taper off meds after months), whereas ADHD and depression are typically long-term maintenance. This means you need more consistent new patient flow with insomnia — but on the flip side, you’re delivering what’s clinically appropriate rather than keeping patients on meds indefinitely just for revenue.

Should I specialize in insomnia or offer it as part of general psychiatry?

Most psychiatrists incorporate insomnia treatment into their general practice — it’s a common comorbidity with anxiety and depression anyway. However, developing expertise in sleep medicine (understanding CBT-I protocols, newer medications like orexin antagonists, managing complex cases) can differentiate you in the market. ‘Sleep psychiatry’ is an emerging subspecialty, and there’s patient demand for providers who truly understand chronic insomnia management beyond just prescribing Ambien.

What’s the biggest mistake providers make in telehealth insomnia prescribing?

Over-relying on pharmacotherapy without behavioral intervention. Medications are effective for short-term relief, but chronic insomnia requires addressing underlying behavioral and cognitive factors. Providers who just refill Ambien month after month without discussing sleep hygiene, stimulus control, or recommending CBT-I are:

1. Delivering suboptimal care
2. Creating dependence on medications
3. Missing opportunities for durable improvement

The best telehealth insomnia providers either deliver basic CBT-I themselves or actively coordinate with digital CBT-I programs and therapists.

State-by-State Requirements Summary Table

The Klarity Health Advantage for Insomnia Providers

If you’re weighing whether to join a telehealth platform or build your own practice from scratch, here’s what platforms like Klarity Health offer:

Eliminate Marketing Risk: Instead of spending $3,000-5,000/month on SEO, Google Ads, and directories with uncertain results, you pay only when qualified patients book appointments. No upfront investment, no wasted ad spend, guaranteed ROI.

Pre-Qualified Patients: Klarity’s intake process matches patients with providers based on specialty, availability, and insurance coverage. You’re not fielding cold calls from people who may not be appropriate for your practice — you’re seeing patients ready for psychiatric evaluation.

Built-In Infrastructure: Telehealth platform, scheduling system, EMR integration, and e-prescribing tools are included. You don’t need to vet vendors, negotiate contracts, or troubleshoot tech issues.

Insurance Credentialing: Klarity handles credentialing with major insurance networks, so you can see insured patients without months of paperwork.

Flexible Schedule: Set your own availability — see patients evenings and weekends if you want, or carve out specific blocks. You’re in control.

Both Insurance and Cash-Pay: Access patients across payment models, maximizing your earning potential.

For psychiatrists looking to expand into telehealth without the operational headaches, or PMHNPs who need a platform that provides supervising physicians in restricted states, Klarity removes the barriers that prevent most clinicians from successfully launching virtual practices.

Compare the economics:

• Solo practice: Spend $4,000/month on marketing, hope to get 15-20 patients, net $1,200-2,000 after marketing costs (if it works)
• Klarity model: Pay per appointment, see 15-20 patients, net $1,500-2,500 with zero marketing spend and zero risk

The choice becomes obvious when you value your time and want predictable income.

Ready to Start Treating Insomnia Patients via Telehealth?

Whether you’re a psychiatrist with full prescribing authority or a PMHNP navigating state-specific scope of practice rules, the demand for accessible insomnia treatment has never been higher. Telehealth removes geographic barriers, reduces no-shows, and allows you to serve patients who might wait months for an in-person appointment.

The regulatory landscape is favorable through at least 2025 for controlled substance prescribing via telemedicine, making this an ideal time to establish or expand your telehealth presence.

Join Klarity Health’s network and start seeing insomnia patients on your schedule, without the marketing gamble or operational complexity of solo practice. We handle patient acquisition, platform infrastructure, and insurance credentialing — you focus on delivering great care.

[Explore Klarity Health’s Provider Network →]

Sources and References

1. California Board of Registered Nursing. (2024). AB 890 Implementation: Nurse Practitioner Practice. Retrieved from https://www.rn.ca.gov/practice/ab890.shtml

2. Texas Medical Board. (2019, updated 2026). Prescribing and Supervision: Advanced Practice Registered Nurses. Retrieved from https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision

3. Florida Nurse Practitioner Network. (2023). Legislative Talking Points: HB 607 and Psychiatric APRN Exclusions. Retrieved from https://www.flanp.org/page/TalkingPoints

4. Rivkin Radler LLP. (April 13, 2022). New Law Allows Experienced NPs to Practice Independently in NY. Rivkin Rounds. Retrieved from https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/

5. Commonwealth Foundation. (December 5, 2022). Nurse Practitioner Reform: Full Practice Authority in Pennsylvania. Retrieved from https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/

6. Nurse Practitioner License. (February 12, 2024). Limitations of Practice as a Nurse Practitioner in Illinois. Retrieved from https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/

7. USA Doctor Network. (June 11, 2025). How to Get Insomnia Prescriptions via Telemedicine. Retrieved from https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3

8. Center for Connected Health Policy. (October 2025). State Telehealth Laws and Reimbursement Policies Report: Fall 2025. Retrieved from https://www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025/

9. Medicare Physician Fee Schedule. (2026). CPT Code Reimbursement Rates. Retrieved from https://www.medfeeschedule.com/

10. NPSchools.com. (2024, Reviewed 2026). Guide to Nurse Practitioner Practice in Florida. Retrieved from https://www.npschools.com/blog/guide-to-np-practice-in-florida

All regulatory information current as of February 26, 2026. Providers should verify current requirements with their state medical or nursing board, as scope of practice and telehealth rules continue to evolve.

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025